Alnylam Pharmaceuticals Joins Alliance to Enhance Genomic Research and Drive Precision Medicine Forward Alnylam Pharmaceuticals has joined the Alliance for Genomic Discovery to expand the genomic dataset that supports the development of precision medicine, enhancing drug discovery capabilities.

Alnylam Pharmaceuticals Joins Alliance to Enhance Genomic Research and Drive Precision Medicine Forward #United_States #San_Diego #Alnylam_Pharmaceuticals #Genomic_Discovery #RNAi_Therapeutics

Alliance for Genomic Discovery Reaches Milestone with 250,000 Genomes to Propel Drug Discovery Forward The Alliance for Genomic Discovery has successfully sequenced 250,000 whole genomes, laying the groundwork for innovative drug development and clinical research.

Alliance for Genomic Discovery Reaches Milestone with 250,000 Genomes to Propel Drug Discovery Forward #USA #Nashville #Illumina #Genomic_Discovery #Nashville_Biosciences